Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine - Related Studies

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

This study has been completed.

Study NCT00127855. Last updated on October 30, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Haemophilus Infection
		Meningococcal Infection

2	Additional conditions recognized in this trial
		Communicable Diseases
		Haemophilus Infections
		Infection
		Meningococcal Infections

3	More general conditions related to this trial
		Bacterial Infections
		Gram-Negative Bacterial Infections
		Neisseriaceae Infections
		Pasteurellaceae Infections

4	Interventions listed in this trial
		Hib-MenCY-TT vaccine

5	Sponsors listed in this trial
		GlaxoSmithKline